BioSpace News Archive

The Medicines Company (NASDAQ:MDCO) (the “Company”) today announced that it proposes to offer $150 million aggregate principal amount of convertible senior notes due 2024, subject to market conditions and other factors.

Kratom, the natural, coffee-like herb associated with better health and well-being, faces many challenges today and it has its best shot at survival if the community tones down the “doomsday rhetoric” and starts working in a more coordinated way to ensure the survival of the botanical, according to the Kratom Trade Association (KTA), which is the only registered trade group representing kratom manufacturers, distributors and retailers.

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, announced today that IBI305, a recombinant humanized anti-VEGF monoclonal antibody being developed as a potential biosimilar to Avastin (Bevacizumab),

The Global Health Innovative Technology (GHIT) Fund has awarded VLP Therapeutics a $3.9 million grant to further develop a novel tetravalent dengue virus-like particle vaccine.

- Today, Walmart and Express Scripts (NASDAQ: ESRX) announced an extension to the companies’ existing network agreement to provide access to Walmart’s prescription services for Express Scripts clients’ covered members.

Indivior PLC (LON: INDV) (“Indivior” or the “Company”) today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied Dr. Reddy’s Laboratories (DRL’s) motion to immediately issue the mandate following the CAFC’s ruling vacating the preliminary injunction (PI).

Relmada Therapeutics, Inc. (OTCQB: RLMD), announced today that clinical data demonstrating increased plasma levels of brain derived neurotrophic factor (BDNF) in healthy subjects treated with REL-1017 (dextromethadone) were presented at the annual American College of Neuropsychopharmacology meeting

Berkeley Lights, Inc. and Novo Nordisk today announced that Novo Nordisk has purchased the Beacon® Optofluidic platform to accelerate workflows in cell line development and to use the platform for future protein and antibody discovery.

On December 7, 2018 at the Loews Regency Hotel in San Francisco, The Academy of Supra-gingival Healthy Dentistry held its first Annual Meeting to a full room of over 70 dentist and dental professionals, all very excited to learn the latest on how, Supra-gingival Healthy Dentistry can provide truly healthier biocompatible dentistry for their patients.

Apexian Pharmaceuticals is shedding light on the question of how pre-leukemic cells transform into full-blown leukemia.